Carbohydrate Metabolism Is Essential for the Colonization of Streptococcus thermophilus in the Digestive Tract of Gnotobiotic Rats

Streptococcus thermophilus is the archetype of lactose-adapted bacterium and so far, its sugar metabolism has been mainly investigated in vitro. The objective of this work was to study the impact of lactose and lactose permease on S. thermophilus physiology in the gastrointestinal tract (GIT) of gnotobiotic rats. We used rats mono-associated with LMD-9 strain and receiving 4.5% lactose. This model allowed the analysis of colonization curves of LMD-9, its metabolic profile, its production of lactate and its interaction with the colon epithelium. Lactose induced a rapid and high level of S. thermophilus in the GIT, where its activity led to 49 mM of intra-luminal L-lactate that was related to the induction of mono-carboxylic transporter mRNAs (SLC16A1 and SLC5A8) and p27Kip1 cell cycle arrest protein in epithelial cells. In the presence of a continuous lactose supply, S. thermophilus recruited proteins involved in glycolysis and induced the metabolism of alternative sugars as sucrose, galactose, and glycogen. Moreover, inactivation of the lactose transporter, LacS, delayed S. thermophilus colonization. Our results show i/that lactose constitutes a limiting factor for colonization of S. thermophilus, ii/that activation of enzymes involved in carbohydrate metabolism constitutes the metabolic signature of S. thermophilus in the GIT, iii/that the production of lactate settles the dialogue with colon epithelium. We propose a metabolic model of management of carbohydrate resources by S. thermophilus in the GIT. Our results are in accord with the rationale that nutritional allegation via consumption of yogurt alleviates the symptoms of lactose intolerance

Influence du gene de nanimse (dw) sur le metabolisme lipidique de la poule pondeuse

SIGLECNRS T Bordereau / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc

Modulation of the caecal gut microbiota of mice by dietary supplement containing resistant starch: impact is donor-dependent

Alterations in the gut microbiota have been associated with a wide range of pathologies and conditions. Maintaining a well-balanced microbiota is a key factor in sustaining good health. Our aim was to investigate the impact of a resistant starch-containing dietary supplement (SymbioIntest (R)) on the composition of the human gut microbiota and on intestinal short chain fatty acid (SCFA) concentration. Human microbiota-associated mice were used. Ex-germ-free mice were inoculated with fecal suspensions from four different donors. Three weeks later, the mice were orally gavaged for 1 month with either a daily dose of 10 mg of SymbioIntest (R) or the vehicle (water) for the negative control group. The composition of the microbiota and SCFA levels were analyzed by 16S rRNA gene sequencing and gas chromatography, respectively. In three groups of mice, SymbioIntest (R) supplementation increased the concentration of caecal butyrate. This was in conjunction with a remodeling of the gut microbiota. OTUs belonging to the Bacteroidaceae, Porphyromonadaceae, Lachnospiraceae and Ruminococcaceae families were affected. In two groups of mice the greatest changes in OTUs were seen in the Faecalibacterium genus. The supplementation's highest impact was observed in mice inoculated with gut microbiota containing a lower number of Ruminococcaceae and Faecalibacterium and a higher number of Prevotellaceae. SymbioIntest (R) supplementation elicited a beneficial effect on the healthy adult gut microbiota by increasing caecal butyrate production and health-promoting taxa. We highlight the fact that screening the gut microbiota may be used for predicting individualized responses to dietary interventions and thus developing personalized nutritional strategies

Extensive Intestinal Resection Triggers Behavioral Adaptation, Intestinal Remodeling and Microbiota Transition in Short Bowel Syndrome

Extensive resection of small bowel often leads to short bowel syndrome (SBS). SBS patients develop clinical mal-absorption and dehydration relative to the reduction of absorptive area, acceleration of gastrointestinal transit time and modifications of the gastrointestinal intra-luminal environment. As a consequence of severe mal-absorption, patients require parenteral nutrition (PN). In adults, the overall adaptation following intestinal resection includes spontaneous and complex compensatory processes such as hyperphagia, mucosal remodeling of the remaining part of the intestine and major modifications of the microbiota. SBS patients, with colon in continuity, harbor a specific fecal microbiota that we called “lactobiota” because it is enriched in the Lactobacillus/Leuconostoc group and depleted in anaerobic micro-organisms (especially Clostridium and Bacteroides). In some patients, the lactobiota-driven fermentative activities lead to an accumulation of fecal d/l-lactates and an increased risk of d-encephalopathy. Better knowledge of clinical parameters and lactobiota characteristics has made it possible to stratify patients and define group at risk for d-encephalopathy crises

Biofilm Formation and Synthesis of Antimicrobial Compounds by the Biocontrol Agent Bacillus velezensis QST713 in an Agaricus bisporus Compost Micromodel

International audienceBacillus velezensis QST713 is widely used as a biological control agent for crop protection and disease suppression. This strain is used industrially in France for the protection of Agaricus bisporus against Trichoderma aggressivum f. europaeum, which causes green mold disease. The efficacy of this biocontrol process was evaluated in a previous study, yet the mode of its action has not been explored under production conditions. In order to decipher the underlying biocontrol mechanisms for effective biofilm formation by strain QST713 in the compost and for the involvement of antimicrobial compounds, we developed a simplified micromodel for the culture of A. bisporus during its early culture cycle. By using this micromodel system, we studied the transcriptional response of strain QST713 in the presence or absence of A. bisporus and/or T. aggressivum in axenic industrial compost. We report the overexpression of several genes of the biocontrol agent involved in biofilm formation in the compost compared to their expression during growth in broth compost extract either in the exponential growth phase (the epsC, blsA, and tapA genes) or in the stationary growth phase (the tapA gene), while a gene encoding a flagellar protein (hag) was underexpressed. We also report the overexpression of Bacillus velezensis QST713 genes related to surfactin (srfAA) and fengycin (fenA) production in the presence of the fungal pathogen in the compost.IMPORTANCE Biocontrol agents are increasingly used to replace chemical pesticides to prevent crop diseases. In the button mushroom field in France, the use of Bacillus velezensis QST713 as a biocontrol agent against the green mold Trichoderma aggressivum has been shown to be efficient. However, the biocontrol mechanisms effective in the Agaricus bisporus/Trichoderma aggressivum/Bacillus velezensis QST713 pathosystem are still unknown. Our paper focuses on the exploration of the bioprotection mechanisms of the biocontrol agent Bacillus velezensis QST713 during culture of the button mushroom (Agaricus bisporus) in a micromodel culture system to study the specific response of strain QST713 in the presence of T. aggressivum and/or A. bisporus

A promising probiotic capable to reduce the impact of undernutrition on the development of sarcopenia

International audienceSarcopenia, worsened by malnutrition, represents ~20% of humans ≥ 60 years and increases risks of falls and dependency of older adults. Protein/energy-based supplementations remain not optimal to maintain muscle mass and function especially if targeted population is with poor appetite. Hence, complementary strategies independent of increased food intake have to be developed to limit sarcopenia. We have shown that very atypical gut microbiota in small intestine-resected patients (i.e., 90% Lactobacilli), when transferred to axenic rats, could optimize the use of dietary nutrients and metabolism. We hypothesized that bacteria from this specific microbiota could be of interest to improve nutrients handling in older adults and limit sarcopenia

A probiotic capable to reduce sarcopenia in undernourished elderly, results from a pre-clinical study

International audienceIn 2050, older adults (65+) will reach 20% of world population with sarcopenic individuals representing a third of them. Specific nutritional strategies based on proteins coupled or not with exercise have shown some beneficial effects to limit sarcopenia but depending of the physio-pathological state, they may not be optimal or not applicable in case of poor appetite or disabilities to perform exercise.Hence, complementary strategies independent of food intake need to be developed to limit sarcopenia. We recently observed on small intestine-resected patients a specific microbiota with a tremendous increased in Lactobacilli. Following the transfer of this specific microbiota in axenic rats, we showed an improved energy metabolism regulation which could be an adaptation of the gut physiology and metabolism to optimize the challenged utilization of nutrients in those patients. We hypothesized that this microbiota could be of interest to optimize energy utilization in malnourished frail elderly and then to limit sarcopenia

Bactéries probiotiques issues d’un patient souffrant du syndrome de grêle court : une stratégie prometteuse pour réduire la sarcopénie chez les personnes âgées sous-alimentées

International audienc

Lacticaseibacillus casei CNCM-I5663 : a probiotic to reduce Sarcopenia in undernourished older people.

International audienceIn 2050, ageing population will reach 35% of European population, within it, 30% will suffer sarcopenia. Sarcopenia is recognized as an hallmark of undernutrition in adults. Nutritional enrichment with proteins and exercise limit sarcopenia, but these strategies are difficult to applicate to frail people because of their loss of appetite, non-compliance for exercise or disability. Based on the existence of a gut-muscle axis and the role of microbiota in supplying energy to host (1), the aim of the study is to isolate a probiotic strain that could protect muscle mass for frail individual. We have used fecal sample of one patient with a short bowel syndrome (SBS) as a source of new strains. This patient has had an extensive surgery shortening his gut length and deeply modifying its intestinal microbiota. Since the gut microbiota of SBS is efficient to rescue energy and is very rich in Lactibacillacea, we isolated lactic acid strains from their faeces(2, 3).. The neamatode Caenorhabditis elegans model was used to select a strain able to protect muscle integrity. Lacticaseibacillus casei CNCM-I5663 strain promotes longevity and maintains the mitochondrial networks of wall muscles in C. elegans. Then, this strain was tested in vivo with aged rastephats (18 months) under moderate caloric restriction (75% of ad libitum), mimicking frail individuals. This strain improves insulin sensitivity (HOMA-IR after 2 months of supplementation with probiotic, ANOVA, p=0.056) and preserves the mass of the rats' hindlimb muscles by 12% compared to the restricted controls (ANOVA, p<0.05)(4).The strain Lacticaseibacillus casei CNCM-I5663 strain could be a promising probiotic to limit sarcopenia in specific population, like undernourished older people